# OnCo record paper-atezolizumab-alveolar-soft-part-sarcoma-chen-nejm-2023 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-atezolizumab-alveolar-soft-part-sarcoma-chen-nejm-2023/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-atezolizumab-alveolar-soft-part-sarcoma-chen-nejm-2023" ;
  schema:name "Atezolizumab for advanced alveolar soft part sarcoma"@en ;
  schema:description "The PD-L1 antibody atezolizumab shrank tumours in about a quarter of patients with advanced alveolar soft part sarcoma, with responses lasting years in a disease resistant to chemotherapy, and became the first approved treatment for this sarcoma."@en ;
  schema:url <https://onco.cc/key-papers/paper-atezolizumab-alveolar-soft-part-sarcoma-chen-nejm-2023/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa2303383>, <https://pubmed.ncbi.nlm.nih.gov/37672694/> ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa2303383> ;
  schema:datePublished "2023"^^xsd:gYear ;
  schema:author "Chen AP, Sharon E, O'Sullivan-Coyne G, et al." ;
  onco:cancers <https://onco.cc/cancers/alveolar-soft-part-sarcoma/> ;
  onco:drugs <https://onco.cc/drugs/atezolizumab/> ;
  onco:journals <https://onco.cc/journals/nejm/> .